ICU Medical, Inc. (NASDAQ:ICUI) VP Virginia Ruth Sanzone sold 1,784 shares of the business’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $174.47, for a total value of $311,254.48. Following the transaction, the vice president now directly owns 102 shares of the company’s stock, valued at $17,795.94. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.

Shares of ICU Medical, Inc. (NASDAQ:ICUI) traded up 0.26% during trading on Thursday, reaching $174.40. The company had a trading volume of 83,783 shares. The company has a market capitalization of $3.46 billion, a P/E ratio of 69.84 and a beta of 0.36. The firm has a 50-day moving average price of $171.32 and a 200-day moving average price of $162.58. ICU Medical, Inc. has a 52-week low of $120.14 and a 52-week high of $176.50.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings results on Wednesday, August 9th. The medical instruments supplier reported $0.52 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.58 by $0.06. The company had revenue of $331.51 million during the quarter, compared to the consensus estimate of $318.30 million. ICU Medical had a return on equity of 7.56% and a net margin of 6.10%. The company’s revenue for the quarter was up 242.8% on a year-over-year basis. During the same period last year, the business posted $1.15 EPS. On average, analysts predict that ICU Medical, Inc. will post $4.11 EPS for the current fiscal year.

ILLEGAL ACTIVITY WARNING: “Virginia Ruth Sanzone Sells 1,784 Shares of ICU Medical, Inc. (ICUI) Stock” was first published by American Banking News and is owned by of American Banking News. If you are reading this article on another publication, it was stolen and republished in violation of United States and international copyright & trademark legislation. The legal version of this article can be accessed at https://www.americanbankingnews.com/2017/09/07/virginia-ruth-sanzone-sells-1784-shares-of-icu-medical-inc-icui-stock.html.

ICUI has been the subject of a number of analyst reports. Zacks Investment Research raised ICU Medical from a “hold” rating to a “strong-buy” rating and set a $195.00 price objective for the company in a research report on Wednesday, July 12th. Roth Capital downgraded ICU Medical from a “buy” rating to a “neutral” rating in a research report on Thursday, May 11th. They noted that the move was a valuation call. BidaskClub raised ICU Medical from a “sell” rating to a “hold” rating in a research report on Friday, August 18th. Gabelli reaffirmed a “buy” rating on shares of ICU Medical in a report on Friday, August 11th. Finally, Sidoti downgraded ICU Medical from a “buy” rating to a “neutral” rating in a report on Tuesday, June 20th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and an average target price of $193.00.

Several hedge funds and other institutional investors have recently made changes to their positions in the stock. BlackRock Inc. lifted its holdings in shares of ICU Medical by 0.6% in the 2nd quarter. BlackRock Inc. now owns 1,780,976 shares of the medical instruments supplier’s stock worth $307,218,000 after purchasing an additional 11,046 shares during the last quarter. Janus Capital Management LLC lifted its holdings in shares of ICU Medical by 178.8% in the 1st quarter. Janus Capital Management LLC now owns 1,439,864 shares of the medical instruments supplier’s stock worth $219,864,000 after purchasing an additional 923,395 shares during the last quarter. Janus Henderson Group PLC bought a new stake in shares of ICU Medical in the 2nd quarter worth approximately $247,072,000. Vanguard Group Inc. lifted its holdings in shares of ICU Medical by 16.3% in the 2nd quarter. Vanguard Group Inc. now owns 1,304,282 shares of the medical instruments supplier’s stock worth $224,989,000 after purchasing an additional 183,133 shares during the last quarter. Finally, Wellington Management Group LLP lifted its holdings in shares of ICU Medical by 12.1% in the 1st quarter. Wellington Management Group LLP now owns 652,897 shares of the medical instruments supplier’s stock worth $99,697,000 after purchasing an additional 70,283 shares during the last quarter. 78.13% of the stock is currently owned by institutional investors and hedge funds.

About ICU Medical

ICU Medical, Inc is engaged in the development, manufacture and sales of medical devices used in infusion therapy, oncology and critical care applications. The Company’s product line includes needlefree connection devices, custom infusion sets, closed system transfer devices (CSTD) for the handling of hazardous drugs, advanced sensor catheters, needlefree closed blood sampling systems, disposable pressure transducer systems and hemodynamic monitoring systems.

Insider Buying and Selling by Quarter for ICU Medical (NASDAQ:ICUI)

Receive News & Ratings for ICU Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ICU Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.